Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 5 of 5 for “"Bomedemstat"”.

  1. Investigation of the effects of LSD1 inhibition on AML immunogenicity and T cell-mediated immune responses

    … effects of a clinical-stage LSD1 inhibitor bomedemstat (IMG-7289) were examined in both human and murine AML cell models in vitro. The results demonstrated that bomedemstat treatment significantly enhanced the expression of class II transactivator (CIITA). It subsequently led to the …

    mcmaster Repository record for Investigation of the effects of LSD1 inhibition on AML immunogenicity and T cell-mediated immune responses (opens in a new tab)

  2. INVESTIGATION OF THE COMBINATION EFFECT OF LSD1 INHIBITION WITH THE NOVEL RARα AGONIST TAMIBAROTENE

    … to study the effects of ATRA, Tamibarotene, and Bomedemstat on differentiation, cell viability, and gene expression. We examined their responses to ATRA, Tamibarotene, and the LSD1 inhibitor Bomedemstat, alone and in combination. Both combinations in RARA-high cells showed synergistic …

    mcmaster Repository record for INVESTIGATION OF THE COMBINATION EFFECT OF LSD1 INHIBITION WITH THE NOVEL RARα AGONIST TAMIBAROTENE (opens in a new tab)

  3. Targeting LSD1 for direct effects and induction of anti-tumor immunity against lethal prostate cancer

    … of strong drug candidates. Here, we characterize bomedemstat (IMG-7289) as a novel, orally-bioavailable, mechanism-based, irreversible LSD1 inhibitor with low nanomolar potency and high specificity. We report activity of bomedemstat in several in vitro and in vivo models of advanced prostate …

    jhu Repository record for Targeting LSD1 for direct effects and induction of anti-tumor immunity against lethal prostate cancer (opens in a new tab)

  4. Pharmacological Inhibition of LSD1/KDM1A in Diffuse Midline Glioma Models and Impact on Kinase Signaling

    … relevant pharmacological LSD1 inhibitor, bomedemstat, and the mitogen-activated protein kinase (MAPK) signaling pathway aiming to uncover potential compensatory resistance mechanisms, in this study. Through intensive screening, I have revealed that LSD1 inhibition with bomedemstat …

    uthsc Repository record for Pharmacological Inhibition of LSD1/KDM1A in Diffuse Midline Glioma Models and Impact on Kinase Signaling (opens in a new tab)

  5. Combined Inhibition of Lysine-Specific Demethylase 1 and Kinase Signaling as a Preclinical Treatment Strategy in Glioblastoma

    … with catalytic LSD1 inhibitors, NCD38 and bomedemstat, and the LSD1 scaffolding inhibitor, seclidemstat. Cells were treated with LSD1 inhibitors alone and in combination with kinase inhibitors, including osimertinib, afatinib, and ulixertinib. The effect on cell viability, proliferation, …

    uthsc Repository record for Combined Inhibition of Lysine-Specific Demethylase 1 and Kinase Signaling as a Preclinical Treatment Strategy in Glioblastoma (opens in a new tab)